| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.04 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.097 | 0.04 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.04 |
| mRNA | FTI-277 | GDSC1000 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.096 | 0.04 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.05 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.092 | 0.05 |